NCT00030979View on ClinicalTrials.gov

Donepezil to Treat Dementia in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

March 31, 2005

Conditions
Parkinson Disease
Interventions
DRUG

Donepezil

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00030979 - Donepezil to Treat Dementia in Parkinson's Disease | Biotech Hunter | Biotech Hunter